Bob Cheng
Overview
Explore the profile of Bob Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Metz M, OHare J, Cheng B, Puchowicz M, Buettner C, Scherer T
Mol Metab
. 2023 Apr;
73:101723.
PMID: 37100238
Objectives: Insulin's ability to counterbalance catecholamine-induced lipolysis defines insulin action in adipose tissue. Insulin suppresses lipolysis directly at the level of the adipocyte and indirectly through signaling in the brain....
2.
OHare J, Zielinski E, Cheng B, Scherer T, Buettner C
Diabetes
. 2011 Mar;
60(4):1055-62.
PMID: 21447652
Objective: The endocannabinoid (EC) system has been implicated as an important regulator of energy homeostasis. In obesity and type 2 diabetes, EC tone is elevated in peripheral tissues including liver,...
3.
Scherer T, OHare J, Diggs-Andrews K, Schweiger M, Cheng B, Lindtner C, et al.
Cell Metab
. 2011 Feb;
13(2):183-94.
PMID: 21284985
White adipose tissue (WAT) dysfunction plays a key role in the pathogenesis of type 2 diabetes (DM2). Unrestrained WAT lipolysis results in increased fatty acid release, leading to insulin resistance...
4.
Muse E, Cheng A, Chen L, Scherer T, Pocai A, Su K, et al.
Nat Med
. 2008 Jun;
14(6):667-75.
PMID: 18516053
Leptin (encoded by Lep) controls body weight by regulating food intake and fuel partitioning. Obesity is characterized by leptin resistance and increased endocannabinoid tone. Here we show that leptin infused...